<a href="https://laohu8.com/S/EUDAW">Euda Health</a> Holdings Subsidiary Reports Sharp Decrease in Net Loss and Improved EPS for H1 2025
A subsidiary of EUDA Health Holdings Ltd. reported its financial results for the six months ended June 30, 2024. The subsidiary recorded revenue from external customers of $1,908,048 for the period, compared to no reported revenue in the same period of the previous year. The cost of revenue was $1,465,976, resulting in a segment gross profit of $442,072. The subsidiary reported a net loss of $16,748,274 for the six-month period, reflecting a substantial increase compared to a net loss of $1,201,696 in the same period of the prior year. The comprehensive loss for the period was $16,793,161, up from $1,176,581 in the previous year's comparable period. No significant updates regarding business operations were disclosed in the reported results.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016547), on October 01, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。